Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Researchers have found that a comprehensive secondary prevention program lasting up to 3 years after myocardial infarction (MI) appears to reduce the risk for a second nonfatal MI and improve lifestyle habits and continuation of medication.
Current cardiac rehabilitation programs (CRPs) after heart disease rely on short-term interventions that are “unlikely to yield long-term benefits” and which fail to adequately prevent discontinuation of medication, say Pantaleo Giannuzzi (Istituto di Ricovero e Cura a Carattere Scientifico, Veruno, Italy) and team in the Archives of Internal Medicine.
The Global Secondary Prevention Strategies to Limit Event Recurrence After Myocardial Infarction (GOSPEL) study randomly assigned 1620 patients who had suffered an MI to receive a long-term, reinforced, multifactorial educational and behavioral intervention after a standard period of rehabilitation.
“The intervention was aimed at individualizing risk factor and lifestyle management, and pharmacological treatments were based on current guidelines,” explains the team.
Comprehensive sessions with one-on-one support were held monthly for 6 months, then once every 6 months for 3 years. Outcomes of patients in this program were compared with those of 1621 who were randomly assigned to receive usual care.
Overall, 556 (17.2%) patients experienced a cardiovascular event. There was no significant reduction in risk for combined heart events, at 16.1% of patients in the intervention group compared with 18.2% in the usual care group, with a hazard ratio (HR) of 0.88. But there was a significant decrease in incidence of individual coronary events and some combinations of outcomes, including a 48% reduction in nonfatal MI (1.4% vs 2.7%, HR=0.52).
“A marked improvement in lifestyle habits (ie, exercise, diet, psychosocial stress, less deterioration of body weight control) and in prescription of drugs for secondary prevention was seen in the intervention group,” the authors write.
They conclude: “After 3 years, the integrated, multifactorial, reinforced approach proved effective in countering the risk factors and medication adherence deterioration over time and was able to induce a considerable improvement in lifestyle habits.”
© 2017 European Society of Cardiology. All rights reserved